Business
AI Stock Market Analysis
MarketWatch reported that Sandisk's stock is rising due to potential AI-driven growth. The Investing Club discussed its portfolio at a morning meeting. Viking Therapeutics' GLP-1 drug, VK2735, showed promising results in clinical trials.
Coverage timeline — 9 articles
MarketWatch
Katie Stockton, of Fairlead Strategies, said she is seeing strong buying momentum in the healthcare, industrial, biotech, insurance and utility sectors
2026-07-10 11:59 UTC
CNBC
If leverage is out of the AI infrastructure stocks, then it's time to get more positive on the theme after their recent decline.
2026-07-30 15:43 UTC
MarketWatch
These companies are all expected to show very rapid revenue growth through 2028.
2026-07-30 15:47 UTC
CNBC
We are buyers of this weakness because we have a longer-term view.
2026-05-05 14:05 UTC
MarketWatch
The largest part of the economy took a hit in April from the fallout from the Iran war, a survey showed, but businesses still grew at a fairly robust pace even as they grew more cautious.
2026-05-05 14:25 UTC
CNBC
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
2026-09-22 15:44 UTC
MarketWatch
Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.
2026-09-22 15:46 UTC
MarketWatch
Larger AI models and inference are turning NAND from a commodity into a critical component, a Rosenblatt analyst said.
2026-09-22 15:48 UTC
MarketWatch
The hottest tech trades of 2026 just got slammed — smart investors are buying anyway.
2026-07-22 12:45 UTC